122 related articles for article (PubMed ID: 11964078)
1. Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue.
Dupont E; Falardeau P; Mousa SA; Dimitriadou V; Pepin MC; Wang T; Alaoui-Jamali MA
Clin Exp Metastasis; 2002; 19(2):145-53. PubMed ID: 11964078
[TBL] [Abstract][Full Text] [Related]
2. Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.
Falardeau P; Champagne P; Poyet P; Hariton C; Dupont E
Semin Oncol; 2001 Dec; 28(6):620-5. PubMed ID: 11740820
[TBL] [Abstract][Full Text] [Related]
3. Neovastat (AE-941) inhibits the airway inflammation and hyperresponsiveness in a murine model of asthma.
Lee SY; Paik SY; Chung SM
J Microbiol; 2005 Feb; 43(1):11-6. PubMed ID: 15765051
[TBL] [Abstract][Full Text] [Related]
4. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
5. Neovastat--a novel antiangiogenic drug for cancer therapy.
Gingras D; Boivin D; Deckers C; Gendron S; Barthomeuf C; Béliveau R
Anticancer Drugs; 2003 Feb; 14(2):91-6. PubMed ID: 12569294
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the contact hypersensitivity response by AE-941 (Neovastat), a novel antiangiogenic agent.
Dupont E; Wang B; Mamelak AJ; Howell BG; Shivji G; Zhuang L; Dimitriadou V; Falardeau P; Sauder DN
J Cutan Med Surg; 2003; 7(3):208-16. PubMed ID: 12574904
[TBL] [Abstract][Full Text] [Related]
7. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions.
Kimura Y; Kido T; Takaku T; Sumiyoshi M; Baba K
Cancer Sci; 2004 Sep; 95(9):758-64. PubMed ID: 15471563
[TBL] [Abstract][Full Text] [Related]
8. The effect of Neovastat (AE-941) on an experimental metastatic bone tumor model.
Weber MH; Lee J; Orr FW
Int J Oncol; 2002 Feb; 20(2):299-303. PubMed ID: 11788892
[TBL] [Abstract][Full Text] [Related]
9. BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.
Gatto C; Rieppi M; Borsotti P; Innocenti S; Ceruti R; Drudis T; Scanziani E; Casazza AM; Taraboletti G; Giavazzi R
Clin Cancer Res; 1999 Nov; 5(11):3603-7. PubMed ID: 10589777
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis.
Dupont E; Savard PE; Jourdain C; Juneau C; Thibodeau A; Ross N; Marenus K; Maes DH; Pelletier G; Sauder DN
J Cutan Med Surg; 1998 Jan; 2(3):146-52. PubMed ID: 9479080
[TBL] [Abstract][Full Text] [Related]
11. Shark cartilage extracts as antiangiogenic agents: smart drinks or bitter pills?
Gingras D; Renaud A; Mousseau N; Béliveau R
Cancer Metastasis Rev; 2000; 19(1-2):83-6. PubMed ID: 11191068
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
Roomi MW; Roomi N; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Oct; 14(4):807-15. PubMed ID: 16142336
[TBL] [Abstract][Full Text] [Related]
13. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.
Yap R; Veliceasa D; Emmenegger U; Kerbel RS; McKay LM; Henkin J; Volpert OV
Clin Cancer Res; 2005 Sep; 11(18):6678-85. PubMed ID: 16166447
[TBL] [Abstract][Full Text] [Related]
14. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis.
Singh SK; Bhusari S; Singh R; Saxena A; Mondhe D; Qazi GN
Vascul Pharmacol; 2007 May; 46(5):333-7. PubMed ID: 17257903
[TBL] [Abstract][Full Text] [Related]
15. Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression.
Lee SY; Chung SM
Vascul Pharmacol; 2007; 47(5-6):313-8. PubMed ID: 17931982
[TBL] [Abstract][Full Text] [Related]
16. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
[TBL] [Abstract][Full Text] [Related]
18. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
Liu N; Lapcevich RK; Underhill CB; Han Z; Gao F; Swartz G; Plum SM; Zhang L; Green SJ
Cancer Res; 2001 Feb; 61(3):1022-8. PubMed ID: 11221828
[TBL] [Abstract][Full Text] [Related]
19. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
20. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels.
Batist G; Patenaude F; Champagne P; Croteau D; Levinton C; Hariton C; Escudier B; Dupont E
Ann Oncol; 2002 Aug; 13(8):1259-63. PubMed ID: 12181250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]